Benzinga | Mar 2, 2021 05:16AM EST

Biocryst Pharmaceuticals Awarded U.S. Patent 10,933,066 'Methods and compositions for treatment of Zika virus infection'

Disclosed are 9-deazaaadenine derivatives of the general formula (I) ##STR00001## and pharmaceutically acceptable salts thereof, wherein A is OH or NH.sub.2, and B is H or NH.sub.2. Methods for treating and/or suppressing a Zika virus infection with the compounds disclosed are also provided. Pharmaceutical compositions comprising the disclosed compounds are also provided. Such pharmaceutical compositions may optionally contain one or more additional active agents.

View Patent Here